跳转至内容
Merck
CN

349887

Sigma-Aldrich

过氧化氢 溶液

contains inhibitor, 35 wt. % in H2O

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
H2O2
CAS号:
分子量:
34.01
Beilstein:
3587191
MDL编号:
UNSPSC代码:
12352304
PubChem化学物质编号:
NACRES:
NA.21

蒸汽压

23.3 mmHg ( 30 °C)

质量水平

方案

33-37% (by potassium permanganate, titration)

表单

liquid

包含

inhibitor

反应适用性

reagent type: oxidant

浓度

35 wt. % in H2O

折射率

n20/D 1.357

沸点

126 °C

mp

−40 °C

密度

1.13 g/mL at 25 °C

储存温度

2-8°C

SMILES字符串

OO

InChI

1S/H2O2/c1-2/h1-2H

InChI key

MHAJPDPJQMAIIY-UHFFFAOYSA-N

正在寻找类似产品? 访问 产品对比指南

一般描述

过氧化氢溶液产品是35%的过氧化氢水溶液。它通常用作绿色氧化剂,并且是比其他氧化剂更好的选择,因为它具有高活性氧含量,且副产物是水。

应用

过氧化氢溶液用作:
  • 在烷基吡啶的N-氧化中用作氧化剂。
  • 是合成GO(石墨烯氧化物)纳米粉末的组分之一。

象形图

CorrosionExclamation mark

警示用语:

Danger

危险分类

Acute Tox. 4 Oral - Aquatic Chronic 3 - Eye Dam. 1 - Skin Irrit. 2 - STOT SE 3

靶器官

Respiratory system

储存分类代码

5.1B - Oxidizing hazardous materials

WGK

WGK 1

闪点(°F)

Not applicable

闪点(°C)

Not applicable

法规信息

易制爆化学品
危险化学品

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Understanding the cross-linking reactions in highly oxidized graphene/epoxy nanocomposite systems
Vryonis O, et al.
Journal of Materials Science, 54(4), 3035-3051 (2019)
Integrated thermodynamic and kinetic model of homogeneous catalytic N-oxidation processes
Wang J, et al.
AIChE Journal, 66(4), e16875-e16875 (2020)
V-, Mo-and W-containing layered double hydroxides as effective catalysts for mild oxidation of thioethers and thiophenes with H2O2
Maciuca AL, et al.
Catalysis Today, 138(1-2), 33-37 (2008)
Shoichi Iriguchi et al.
Blood, 125(2), 370-382 (2014-10-29)
Although overexpression of T-bet, a master transcription factor in type-1 helper T lymphocytes, has been reported in several hematologic and immune diseases, its role in their pathogenesis is not fully understood. In the present study, we used transgenic model mice
James R Van Brocklyn et al.
Cancer research, 74(19), 5364-5370 (2014-08-12)
Glioblastoma remains a devastating disease for which novel therapies are urgently needed. Here, we report that the Aurora-A kinase inhibitor alisertib exhibits potent efficacy against glioblastoma neurosphere tumor stem-like cells in vitro and in vivo. Many glioblastoma neurosphere cells treated

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门